AscleStem® Cardiomyocyte Differentiation Medium

Cat.No. Size Price
13166-05 500 mL 來電價
15345-24 11 mL 來電價
15346-14 5 mL 來電價
  • 無血清培養基
  • 將 iPS cells 分化為心肌細胞 cardiomyocytes
  • 採用無細胞激素 cytokine-free protocol。以小分子化合物替代方式降低成本
  • 相容於單層培養 (adherent culture) 及類胚體 (embryoid body, EB) (suspension culture) 培養方法
  • 與東京大學合作研發
  • 搭配補充劑 Supplement A (#15345-24) 以及 Supplement B (#15346-14) 使用
Share:

AscleStem® Cardiomyocyte Differentiation Medium(#13166-05)、Supplement A for C.D. Medium(#15345-24)及 Supplement B for C.D. Medium(#15346-14)為無血清培養基及無血清添加劑,用於誘導人類多能幹細胞分化為心肌細胞。

本培養流程以小分子化合物取代細胞激素(cytokines),有望降低培養成本,並可同時適用於單層培養法(貼附培養)及類胚體形成法(懸浮培養)。

 

1. Cell morphology and immunostaining results after differentiation 

Human iPSC cell lines were differentiated into cardiomyocytes using two culture methods: the monolayer culture method and the embryoid body formation method. Expression of the cardiomyocyte marker cTnT was confirmed by immunostaining using purified cells.

2. Response of cardiomyocytes differentiated by two culture methods to isoproterenol
The responsiveness of cardiomyocytes differentiated from human iPS cells by two culture methods (monolayer culture and embryoid body formation) to isoproterenol was evaluated using the SI8000 Cell Motion Imaging System (Sony). Similar results were obtained with both methods.

檔案名稱 說明 上傳日期 下載
產品簡介
2026100703195051.pdf
2026100703195051.pdf 2026-10-07 11:19:50
Protocol
2026100703111218.pdf
2026100703111218.pdf 2026-10-07 11:11:12

同類別的其他產品: